91AV

BSc Hons, DPhil, FRSC, CChem

Senior leader, non-executive director, independent consultant, executive coach and mentor. Extensive track record of delivering in line, project and scientific leadership roles across all stages of pharmaceutical R&D.

Expert knowledge of all stages of new drug discovery, development, scale-up, manufacture, supply and commercialisation. 91AV, Manufacturing and Control (drug substance and product) primary author, reviewer and approver of multiple New Chemical Entity regulatory submissions from phase I through to NDA across EU, US and Asian territories. Knowledge of digital health and devices.

EPSRC council member. EPSRC peer reviewer, Innovate UK assessor, UKRI Future Leaders fellowship panellist. Highly active and influential across a broad portfolio of academic, industrial, healthcare, public sector and policy related matters.

A track record of adding value at the interface of industry, academia and the public sector. Professional network extends across Big Pharma/SME and the healthcare technology sector. Business start-up advisor with working as strategic advisor at Bionow, expert panel member at BioCity, mentor/coach at University of Oxford Foundry. Network also extends into senior leadership across many of the leading UK universities.

A lucid communicator who sets and provides clarity on strategic direction. Tenacious, delivery focused, challenges established practice, affects change and drives improvement.

Excels as a listener, team builder, coach and facilitator. Ameliorative, optimistic, creative, dares to be different. Extensive international leadership responsibilities across the UK, Sweden, US and China including internal and external collaborations across and beyond the pharmaceutical sector and academia.